Insights On CONTRACT PHARMA MANUFACTURING
-
Reducing Risk And Timelines In Cell Line Development
3/25/2025
Accelerate your biologic development by adopting faster, more reliable clone selection methods that reduce time and resources while improving the likelihood of identifying stable, high-producing cell lines.
-
Streamlining Antibody Capture With Multi-Column Chromatography
3/25/2025
Explore innovative solutions to overcome the limitations of traditional batch chromatography, improving efficiency, reducing costs, and optimizing production for complex biologics like monoclonal antibodies.
-
Overcoming Challenges To High-Concentration Formulation Development
3/25/2025
Explore how the S-HiCon™ platform optimizes high-concentration therapeutic antibody formulations, overcoming stability and manufacturability challenges to deliver safe, effective therapies.
-
Choosing The Right Tech To Optimize Processes And Reduce Costs For Therapeutic Proteins
3/25/2025
Discover how scalable and cost-effective manufacturing solutions can optimize your biopharmaceutical production, ensuring the successful commercialization of your therapeutic protein and broader patient access.
-
Diversifying Single-Use Technology With Cytiva XDR Bioreactors
3/25/2025
Explore how our flexible single-use bioreactor systems, including the Cytiva Xcellerex Disposable Reactors, can efficiently scale your production while maintaining process consistency and product quality.
-
New Protein A Device Set To Redefine Biomanufacturing
3/25/2025
Discover how the Gore Protein A Membrane Device, in collaboration with AGC Biologics, can revolutionize your manufacturing processes, enhancing efficiency, scalability, and innovation from discovery to GMP-level production.
-
Strengthening Europe's Advanced Therapy Supply Chain
3/25/2025
Ensure the seamless development and commercialization of your ATMPs in Europe with integrated supply chain solutions that optimize logistics, biostorage, and regulatory compliance.
-
The Gateway To Europe: How The Stevenage Supply Chain Hub Supports ATMP Development
3/25/2025
Ensure seamless access to European clinical trials and markets with GMP-compliant logistics, regulatory support, and risk mitigation to protect the integrity of your advanced therapies.
-
How Our Recent Innovative Solutions Meet Today's Supply Chain Challenges
3/25/2025
When advanced therapy organizations place innovation at the heart of their strategy for overcoming supply chain challenges, they ultimately prioritize the most important stakeholder — the waiting patient.
-
Bora Pharmaceuticals: A Future Focused CDMO
3/25/2025
Specializing in formulation development, clinical and commercial manufacturing, and advanced packaging solutions, we bring expertise across a diverse range of dosage forms.